Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber

[News]

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

More... (https://www.news-medical.net/news/20230526/Phase-3-studies-for-rectal-brain-and-kidney-cancers-to-be-presented-by-Dana-Farber-researchers-at-ASCO-2023.aspx)